GIE Associate Editor Thiruvengadam Muniraj, MD, highlights this article from the July issue: “Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study” by Ali Lahooti, BS, et al. As the global obesity epidemic intensifies, the demand for durable, effective, and less-invasive interventions continues to rise. Although bariatric surgery remains the reference standard, its uptake …
Tag: Obesity
Radiofrequency vapor ablation for duodenal mucosal ablation in the treatment of type 2 diabetes: results from the first-in-human pilot study
Post written by Benjamin Norton, MD, from Cleveland Clinic London, London, United Kingdom. We are currently experiencing an obesity and diabetic epidemic. We know that the number of people living with type 2 diabetes (T2D) is expected to rise worldwide to alarming rates (1.31 billion by 2050).1 We are seeing an explosion in the number …
Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study
Post written by Ali Lahooti, MD, and Reem Z. Sharaiha, MD, MSc, from the Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Our study aimed to prospectively evaluate the long-term effectiveness of endoscopic sleeve gastroplasty (ESG) as a standalone therapy for treating obesity and its related comorbidities over a period of …
Automatic endoscopic gastroplasty for the treatment of obesity: results from a prospective multicenter study (with video)
Post written by Maria Valeria Matteo, MD, from Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. This study is a prospective multicenter investigation aimed at assessing the safety, efficacy, and usability of the EndoZip suturing device (Nitinotes Ltd, Cesarea, Israel) for automatic endoscopic gastroplasty in the treatment of class 1 …
Prospective, single-arm multicenter, international, observational postmarket study to assess the safety and efficacy of a triangulation platform for treating patients requiring endoscopic gastroplasty
Post written by Maria Valeria Matteo, MD, from Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. This study is a prospective, multicenter, international, observational postmarket registry aimed at assessing the safety and efficacy of the Endomina triangulation platform (Endo Tools Therapeutics, Gosselies, Belgium) for endoscopic gastroplasty in treating obesity. It specifically evaluates …
Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD
Post written by Ramzi Mulki, MD, from the University of Alabama at Birmingham, Birmingham, Alabama, USA. This study focused on evaluating the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on gastric mucosal visibility and retained contents during EGD. Specifically, it investigated whether GLP-1RAs use affects visibility scores (with validated scores) and retained contents, which could …
Endoscopic tips for intragastric balloon use for obesity: what you need to know
Post written by Carlos Paolo Francisco, MD, FPCP, FPSG, FPSDE, from Singapore General Hospital, Singapore, Singapore, and St. Luke's Medical Center–Global City, Manila, Philippines. The intragastric balloon (IGB) offers a less-invasive alternative for managing obesity and its associated comorbidities, whether as a primary intervention or a bridge to bariatric surgery. Despite IGB's potential to address the …
Continue reading Endoscopic tips for intragastric balloon use for obesity: what you need to know
Endoscopic sleeve gastroplasty as an early tool against obesity: a multicenter international study on an overweight population
Post written by Vitor Ottoboni Brunaldi, MD, MSc, PhD, from the Gastroenterology and Hepatology Division, Mayo Clinic, Rochester, Minnesota, USA, Surgery and Anatomy Department, Ribeirao Preto Medical School, University of Sao Paulo, and Gastrointestinal Endoscopy Unit, University of Sao Paulo Medical School, Brazil. This study investigated the efficacy of endoscopic sleeve gastroplasty (ESG) in inducing weight …
Endoscopic sleeve gastroplasty in peritoneal dialysis
Post written by Avik Sarkar, MD, from the Department of Gastroenterology, Robert Wood Johnson Medical Center, New Brunswick, New Jersey, USA. We describe the case of a 51-year-old woman with diabetes, uncontrolled hypertension, ESRD on PD for 3 years, and morbid obesity that failed to respond to lifestyle and dietary modification for weight loss. The …
Continue reading Endoscopic sleeve gastroplasty in peritoneal dialysis
Modified primary obesity surgery endoluminal (POSE-2) procedure for the treatment of obesity
Post written by Ravishankar Asokkumar, MBBS, MRCP, and Gontrand Lopez-Nava, MD, PhD, from the Bariatric Endoscopy Unit, HM Sanchinarro University Hospital, Madrid, Spain, and the Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore. We described a novel primary endoscopic approach to treat obesity using the incision-less operating platform (USGI Medical, USA). We have shared …
endoscopedia.com 